Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artelo Biosciences Inc ARTL

Healthcare
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system (ECS), a family of receptors and neurotransmitters that form a biochemical communication network throughout the body. It is developing a dual cannabinoid agonist for the G protein-coupled receptor... see more

Recent & Breaking News (NDAQ:ARTL)

Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th

GlobeNewswire June 1, 2022

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

Accesswire May 16, 2022

Artelo Biosciences to Present at the H.C. Wainwright Global Investment Conference on May 24th

GlobeNewswire May 16, 2022

Artelo Biosciences to Present at MicroCap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

Accesswire May 13, 2022

Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update

GlobeNewswire May 12, 2022

Artelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New York

Newsfile April 26, 2022

Artelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New York

Newsfile April 25, 2022

Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia

GlobeNewswire April 13, 2022

Artelo Expands Collaboration with Trinity College Dublin to Investigate Cellular Biology of Fatty Acid Binding Protein (FABP) Inhibition In Cancer

GlobeNewswire March 28, 2022

Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

GlobeNewswire March 22, 2022

Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update

GlobeNewswire March 21, 2022

Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol

GlobeNewswire March 2, 2022

Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update

GlobeNewswire January 12, 2022

Artelo Anticipates Accelerated Clinical Development for ART27.13 Following Its Classification Change in the United Kingdom

GlobeNewswire January 11, 2022

Artelo Biosciences Leadership to Participate on Endocannabinoid Panel at the H.C. Wainwright BioConnect 2022 Virtual Conference

GlobeNewswire January 10, 2022

Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update

GlobeNewswire November 29, 2021

Artelo Biosciences to Present at the Q4 Investor Summit on November 17th

Newsfile November 11, 2021

Artelo Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

GlobeNewswire September 8, 2021